SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019185
Filing Date
2019-05-14
Accepted
2019-05-14 17:16:46
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20190331.htm 10-Q 1600441
2 EX-31.1 tcon-ex311_7.htm EX-31.1 9267
3 EX-32.1 tcon-ex321_6.htm EX-32.1 5372
  Complete submission text file 0001564590-19-019185.txt   6427964

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20190331.xml EX-101.INS 1524068
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20190331.xsd EX-101.SCH 56885
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20190331_cal.xml EX-101.CAL 39382
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20190331_def.xml EX-101.DEF 154721
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20190331_lab.xml EX-101.LAB 369454
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20190331_pre.xml EX-101.PRE 264090
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 19823874
SIC: 2836 Biological Products, (No Diagnostic Substances)